Workflow
盈利预测修正
icon
Search documents
Check Point Software (CHKP) Q1 Earnings and Revenues Beat Estimates
ZACKS· 2025-04-23 12:05
Core Viewpoint - Check Point Software reported quarterly earnings of $2.21 per share, exceeding the Zacks Consensus Estimate of $2.19 per share, and showing an increase from $2.04 per share a year ago, indicating a positive earnings surprise of 0.91% [1] Financial Performance - The company achieved revenues of $637.8 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.22% and reflecting a year-over-year increase from $598.8 million [2] - Over the last four quarters, Check Point has exceeded consensus EPS estimates three times and has also topped consensus revenue estimates three times [2] Stock Performance - Check Point shares have appreciated approximately 13.7% since the beginning of the year, contrasting with the S&P 500's decline of 10.1% [3] - The current consensus EPS estimate for the upcoming quarter is $2.37, with expected revenues of $662.72 million, and for the current fiscal year, the EPS estimate is $9.91 on revenues of $2.71 billion [7] Industry Outlook - The Zacks Industry Rank indicates that the Security industry is currently in the top 29% of over 250 Zacks industries, suggesting a favorable outlook as the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]
BiomX (PHGE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2025-04-18 14:56
Group 1: Stock Performance and Technical Analysis - Shares of BiomX Inc. (PHGE) have lost 7.9% over the past two weeks, but a hammer chart pattern formed in the last trading session suggests potential support and a possible trend reversal [1] - The hammer pattern indicates a nearing bottom with potential exhaustion of selling pressure, which is supported by rising optimism among Wall Street analysts regarding the company's future earnings [2][7] - The hammer chart pattern is characterized by a small candle body and a long lower wick, signaling that bears may have lost control over the price during a downtrend [4][5] Group 2: Earnings Estimates and Analyst Ratings - There has been a 34.9% increase in the consensus EPS estimate for the current year over the last 30 days, indicating that sell-side analysts expect better earnings than previously predicted [8] - PHGE currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9] - The positive trend in earnings estimate revisions is a bullish indicator that may lead to price appreciation in the near term [7][9]
Wall Street Analysts See a 764.18% Upside in Corbus Pharmaceuticals (CRBP): Can the Stock Really Move This High?
ZACKS· 2025-04-18 14:56
Group 1 - Corbus Pharmaceuticals (CRBP) closed at $6.03, with a 0.5% gain over the past four weeks, and has a mean price target of $52.11, indicating a potential upside of 764.2% [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $12.31, where the lowest estimate is $35 (480.4% increase) and the highest is $73 (1110.6% increase) [2] - Analysts show strong agreement on CRBP's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for CRBP's current year earnings has increased by 0.1% over the last 30 days, with one estimate moving higher and no negative revisions [12] - CRBP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [10][13]
Is Bit Digital (BTBT) a Buy as Wall Street Analysts Look Optimistic?
ZACKS· 2025-04-18 14:35
Group 1 - Bit Digital, Inc. (BTBT) has an average brokerage recommendation (ABR) of 1.00, indicating a Strong Buy based on five brokerage firms' recommendations, all of which are Strong Buy [2][5] - Despite the Strong Buy recommendation, relying solely on brokerage recommendations may not be advisable as studies show they often fail to guide investors effectively [5][10] - Brokerage analysts tend to exhibit a strong positive bias in their ratings, with a ratio of five "Strong Buy" recommendations for every "Strong Sell" [6][10] Group 2 - The Zacks Rank, a proprietary stock rating tool, is a more reliable indicator of near-term price performance, classifying stocks from Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell) [8][11] - The Zacks Rank is based on earnings estimate revisions, which are strongly correlated with near-term stock price movements, unlike the ABR which may not be up-to-date [11][12] - For Bit Digital, the Zacks Consensus Estimate for the current year remains unchanged at -$0.02, leading to a Zacks Rank 3 (Hold), suggesting caution despite the Buy-equivalent ABR [13][14]
Wall Street Analysts Think IHS Holding (IHS) Could Surge 45.06%: Read This Before Placing a Bet
ZACKS· 2025-04-16 14:55
Group 1 - IHS Holding (IHS) shares have increased by 14.2% in the past four weeks, closing at $5.06, with a mean price target of $7.34 indicating a potential upside of 45.1% [1] - The average of eight short-term price targets ranges from a low of $4 to a high of $16, with a standard deviation of $3.80, suggesting variability in analyst estimates [2] - Analysts show a consensus that IHS will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][10] Group 2 - The Zacks Consensus Estimate for IHS has increased by 30.9% over the past month, with no negative revisions, indicating strong earnings prospects [11] - IHS holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, suggesting significant potential upside [12]
Wall Street Analysts Believe Central Garden (CENTA) Could Rally 29.67%: Here's is How to Trade
ZACKS· 2025-04-16 14:55
Group 1 - Central Garden (CENTA) shares have increased by 1.5% over the past four weeks, closing at $32.26, with a mean price target of $41.83 indicating a potential upside of 29.7% [1] - The average price targets from analysts range from a low of $31 to a high of $50, with a standard deviation of $6.31, suggesting variability in estimates [2] - Analysts are optimistic about CENTA's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][10] Group 2 - The Zacks Consensus Estimate for the current year has increased by 0.1% over the past month, with one estimate rising and no negative revisions [11] - CENTA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [12] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [12]
Wall Street Analysts See Energy Fuels (UUUU) as a Buy: Should You Invest?
ZACKS· 2025-04-16 14:30
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Energy Fuels (UUUU) .Energy Fuels currently has an average brokerage recom ...
How Much Upside is Left in Couchbase (BASE)? Wall Street Analysts Think 46.58%
ZACKS· 2025-04-15 14:55
Core Viewpoint - Couchbase, Inc. (BASE) has seen a 10.9% increase in share price over the past four weeks, closing at $15.05, with analysts suggesting a potential upside of 46.6% based on a mean price target of $22.06 [1] Group 1: Price Targets and Analyst Consensus - The mean estimate consists of 16 short-term price targets with a standard deviation of $2.74, indicating variability among analysts; the lowest estimate suggests a 6.3% increase, while the highest predicts a 72.8% surge to $26 [2] - A low standard deviation in price targets indicates strong agreement among analysts regarding the stock's price movement direction, serving as a starting point for further research [8] - Analysts' growing optimism regarding BASE's earnings prospects is reflected in the upward revisions of EPS estimates, which correlate with potential stock price increases [10] Group 2: Earnings Estimates and Zacks Rank - Over the past 30 days, one earnings estimate for BASE has increased, leading to a 0.1% rise in the Zacks Consensus Estimate, with no negative revisions [11] - BASE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [12]
BWX (BWXT) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-04-10 17:01
Core Viewpoint - BWX Technologies (BWXT) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors often base their valuation models on earnings estimates, leading to buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for BWX reflects an improvement in the company's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - BWX is projected to earn $3.50 per share for the fiscal year ending December 2025, representing a year-over-year increase of 5.1% [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - BWX's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
Strength Seen in Organon (OGN): Can Its 8.5% Jump Turn into More Strength?
ZACKS· 2025-04-10 14:15
Organon (OGN) shares soared 8.5% in the last trading session to close at $12.64. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 25.3% loss over the past four weeks.Organon stock surged amid a broader market rebound following the Trump administration’s announcement of a temporary halt on reciprocal tariffs for most countries. The market is also upbeat about Organon’s recently acquired regulatory and commercial rights in the Unite ...